Pleasanton, California - Boster Bio Technology unlocks insights into cancer and neurological disorders with high-quality ...

The global cell culture market is projected to grow at a CAGR of 12% from 2025 to 2030. This growth is driven by increasing ...

Agilent Technologies Inc. (NYSE: A) announced today its participation at the American Association for Cancer Research (AACR) ...

Dianthus Therapeutics targets severe autoimmune diseases with DNTH103. Read more on DNTH's promise amid competitive ...

Nandita Vijayasimha, Bengaluru Tuesday, April 22, 2025, 08:00 Hrs [IST] ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Nationwide, 58% of Medicare beneficiaries living in rural areas are enrolled in stand-alone prescription drug plans in 2025.

As of today, Kelun-Biotech has initiated 8 registrational clinical studies in China. MSD has initiated 12 ongoing Phase 3 global clinical studies of sac-TMT as a monotherapy or with pembrolizumab or ...

Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...

Proteomics profiling of a pre-metastatic colorectal cancer cohort identifies four proteomics-based subtypes and highlights ...